Cumberland Pharma hopes for $115M in IPO

Cumberland Pharmaceuticals, a Nashville, Tenn., specialty pharmaceutical company with a hodgepodge of acquired products, priced its IPO and now hopes to raise as much as $115 million. The company plans to offer 6.25 million shares, plus a possible overallotment of 937,000 additional shares, at a price between $14 and $16 apiece. The offering would value Cumberland at as much as $403 million.

Next Story: Trulite to release handy fuel cell for consumers
Previous Story: Phone service Jangl lands four new partners

Bookmark and Share

Tags: , ,

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.